Inactivation of NF-κB in CRC cells can also be induced by indomethacin (125–250 μM) and sulindac sulfone (300–500 μM), a sulindac metabolite that lacks COX inhibitory activity [34]. This evidence concerns the gene NFKB1 and colorectal carcinoma.